Elawyers Elawyers
Ohio| Change

Henry v. Angelini Pharma Inc., 2:17-CV-02593-TLN-KJN. (2018)

Court: District Court, E.D. California Number: infdco20180314a08 Visitors: 14
Filed: Mar. 12, 2018
Latest Update: Mar. 12, 2018
Summary: ORDER GRANTING STIPULATION TO AMEND COMPLAINT AND TO EXTEND TIME TO ANSWER OR OTHERWISE RESPOND TO PLAINTIFF'S FORTHCOMING AMENDED COMPLAINT TROY L. NUNLEY , District Judge . By stipulation of Plaintiff Toby Henry and Defendants Endo Health Solutions Inc.; Endo Pharmaceuticals Inc.; Teva Pharmaceuticals USA, Inc.; Angelini Pharma Inc.; Angelini; Angelini LaboPharm LLC; and Gruppo Angelini, and for good cause shown, IT IS HEREBY ORDERED that Plaintiff shall file his amended complaint on or
More

ORDER GRANTING STIPULATION TO AMEND COMPLAINT AND TO EXTEND TIME TO ANSWER OR OTHERWISE RESPOND TO PLAINTIFF'S FORTHCOMING AMENDED COMPLAINT

By stipulation of Plaintiff Toby Henry and Defendants Endo Health Solutions Inc.; Endo Pharmaceuticals Inc.; Teva Pharmaceuticals USA, Inc.; Angelini Pharma Inc.; Angelini; Angelini LaboPharm LLC; and Gruppo Angelini, and for good cause shown,

IT IS HEREBY ORDERED that Plaintiff shall file his amended complaint on or before March 15, 2018. This amended complaint due on or before March 15, 2018 will not affect Plaintiff's right to amend as a matter of course under Federal Rule of Civil Procedure 15(a)(1)(B).

IT IS HEREBY ORDERED that these Defendants are granted an extension of time to answer or otherwise respond to Plaintiff's Complaint, pending the filing of Plaintiff's forthcoming amended complaint which shall be filed on or before March 15, 2018.

IT IS HEREBY ORDERED that these Defendants shall answer or otherwise respond to Plaintiff's forthcoming amended complaint no later than 14 days after its filing.

Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer